期刊文献+

比较泮托拉唑与奥美拉唑对消化性溃疡出血患者止血效果、不良反应及复发率的影响 被引量:11

Pantoprazole and omeprazole for treating peptic ulcer bleeding:Hemostasis effect,adverse reactions and relapse
下载PDF
导出
摘要 目的比较不同药物对消化性溃疡出血患者止血效果、不良反应及复发率的影响.方法随机选取衢州市人民医院2014-05/2016-05收治的80例消化性溃疡出血患者,依据治疗方法将这些患者分为泮托拉唑组(n=40)和奥美拉唑组(n=40)两组,对两组患者的黑便次数、呕血次数、出血量、出血停止时间、临床疗效、不良反应发生情况及复发情况进行统计分析.结果治疗后1、3 d泮托拉唑组患者的出血量均显著少于奥美拉唑组(P<0.05),出血停止时间显著短于奥美拉唑组(P<0.05);两组患者治疗的总有效率97.5%(39/40)、95.0%(38/40),不良反应发生率及复发率之间的差异均不显著(P>0.05).结论泮托拉唑对消化性溃疡出血患者止血效果较奥美拉唑好,更能早期有效减少患者的出血量,缩短患者的出血停止时间,但二者对患者不良反应发生率及复发率的影响之间的差异均不显著. AIM To compare pantoprazole with omeprazole in patients with peptic ulcer bleeding with regard to hemostasis effect,adverse reactions and relapse.METHODS Eighty patients with peptic ulcer bleeding who were treated at our hospital from May 2014 to May 2016 were randomly selected and divided into either a pantoprazole group(n=40) or an omeprazole group(n=40).The number of black stools,vomiting times,amount of bleeding,time to hemostasis,clinical efficacy,adverse events and recurrence were compared between the two groups.RESULTS The bleeding at 1 d and 3 d after treatment was significantly less(P 〈0.05),and the time to hemostasis was significantly shorter in the pantoprazole group than in the omeprazole group(P 〈0.05).The total effective rate[97.5%(39/40) us 95.0%(38/40)],the incidence of adverse reactions[25.0%(10/40) us 22.5%(9/40)]and recurrence rate[0 us 2.5%(1/40)]did not differ significantly between the two groups(P 〉0.05).CONCLUSION The hemostasis effect of pantoprazole is better than that of omeprazole in patients with peptic ulcer bleeding.Pantoprazole is more effective in reducing the amount of bleeding and shortening the time to hemostasis,although there is no significant difference in the incidence of adverse reactions and recurrence rate between the two groups.
出处 《世界华人消化杂志》 CAS 2016年第28期4008-4012,共5页 World Chinese Journal of Digestology
关键词 泮托拉唑 奥美拉唑 消化性溃疡出血 止血效果 不良反应 复发率 Pantoprazole Omeprazole Peptic ulcer bleeding Hemostasis effect Adverse reactions Relapse
  • 相关文献

参考文献11

二级参考文献66

  • 1郑向东,周莉莉.泮托拉唑与奥美拉唑治疗消化性溃疡并出血临床分析[J].岭南急诊医学杂志,2005,10(1):28-29. 被引量:19
  • 2刘佩言,傅桂英,田保华,赵生民,刘宝兴.乙型肝炎疫苗小剂量皮内接种法的免疫效果观察[J].中华流行病学杂志,1989,10(2):109-112. 被引量:3
  • 3陆文婷.药物经济学及其在药品费用控制中的作用[J].医学与哲学,2005,26(10S):58-58. 被引量:10
  • 4周银.内镜下云南白药治疗溃疡性上消化道出血疗效观察[J].现代中西医结合杂志,2006,15(2):198-198. 被引量:3
  • 5Ghosh S, Watts D, Kinnear M. Management of gas- trointestinal haemorrhage. Postgrad Med J 2002; 78: 4-14.
  • 6Vreeburg EM, Levi M, Rauws EA, Deventer SJ, Snel P, Bartelsman JW, Ten Cate JW, Tytgat GN. En- hanced mucosal fibrinolytic activity in gastroduo- denal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Pharmacol Ther 2001; 15: 639-646.
  • 7Simon B, Cremer M, Dammann HG, Hentschel E, Keohane PP, Mulder H, Mtlller P, Sarles H. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe. Scand J Gastroenterol Suppl 1987; 136: 61-70.
  • 8Breuer T, Kim JG, el-Zimaity HM, Nakajima S, Ota H, Osato M, Graham DY. Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. Aliment Pharmacol Ther 1997; 11:939-942.
  • 9Lo WC, Lin HJ, Wang K, Perng CL, Lee SD. Clar- ithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease. Zhonghua Yixue Zazhi (Taipei) 1997; 59: 171-176.
  • 10Thomson AB, Mahachai V, Bailey RJ, Kirdeikis P, Zuk L, Marriage B, Simpson I, Jamali F. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease. J Gastroenterol Hepatol 1996; 11:1171-1176.

同被引文献85

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部